Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
ISBN 9812380671
& Thomas, G
Therapeutic Research Protocol Dose: 2 mg Tesamorelin + 300 mcg Ipamorelin Duration: 12 16 weeks Frequency: Daily, evening administration Cycle Interval: 6 8 weeks off before repeating Goal / Description: Higher-dose protocol for visceral fat reduction and IGF-1 elevation studies
At 8 Weeks By Week 8 (2 months), more visible changes often begin to show for many users who are consistent
It is sterile and nonpyrogenic
US$ 25.74
US$ 28.68
US$ 25.59
US$ 28.52
